| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | $5.7B | $4.5B | $3.9B | $4.8B |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | $0.8B | $0.7B | $0.6B | $0.6B |
| Operating Income | $-0.1B | $-0.1B | $0.0B | $0.1B |
| Net Income | $-0.1B | $-0.3B | $0.0B | $0.1B |
| EPS (Basic) | $-0.59 | $-2.17 | $0.03 | $0.80 |
| EPS (Diluted) | $-0.59 | $-2.17 | $0.03 | $0.79 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $3.3B | $3.4B | $1.8B | $2.0B |
| Current Assets | $1.3B | $1.3B | $0.8B | $1.0B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.1B |
| Total Liabilities | — | — | — | — |
| Current Liabilities | $1.0B | $1.1B | $0.7B | $0.8B |
| Stockholders' Equity | $1.5B | $1.6B | $0.6B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $-0.0B | $0.1B | $0.3B |
| Investing Cash Flow | $-0.1B | $-1.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.1B | $0.0B | $0.1B | $0.1B |
| Financing Cash Flow | $0.0B | $1.1B | $-0.1B | $-0.2B |